SRX Global Employees

SRX Global had 7 employees as of December 31, 2025. That makes SRX Global the 41,093rd largest employer in the world and 6,383rd in the United States.

Employees

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$8,571

Market Cap

26.74M

Employees Chart

Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	7	-	-

Related Stocks

Company Name	Employees
The Hain Celestial Group	1,800
Bridgford Foods	663
Wing Yip Food Holdings Group	410
BranchOut Food	314
Borealis Foods	140
Coffee Holding Co.	92
BioHarvest Sciences	89
DDC Enterprise	42

Employee Rankings

SRXH News

5 days ago - SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform - GlobeNewsWire
6 days ago - SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies - GlobeNewsWire
7 days ago - SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim - GlobeNewsWire
19 days ago - SRX Global says adds investment in Onconetix - TheFly
19 days ago - SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO) - GlobeNewsWire
20 days ago - SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar - GlobeNewsWire
5 weeks ago - SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company - GlobeNewsWire
6 weeks ago - SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers - GlobeNewsWire

More News